Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.
Raxone®/Catena® (idebenone)
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Interferon-beta in pediatric multiple sclerosis patients: safety in short-term prescription.
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes.
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Serum from interferon-β-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
American Society for Cell Biology Annual Meeting
Santhera and NIH collaborate to evaluate Catena® in primary progressive multiple sclerosis
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
Effect of Natalizumab on Circulating CD4(+) T-Cells in Multiple Sclerosis.
Lithium Controls Central Nervous System Autoimmunity through Modulation of IFN-γ Signaling.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Society for Neuroscience Annual Meeting
New Drugs Online report for idebenone
Rituximab and multiple sclerosis.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis

Pages